Evidence map›Paper›PMID 26739140›Full record

ReviewPediatric radiology2016

The neuroimaging of Leigh syndrome: case series and review of the literature.

Eliana Bonfante, Mary Kay Koenig, Rahmat B Adejumo, Vinu Perinjelil, Roy F Riascos

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Pediatric radiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. BiallelicBrain communications · 2025
    Article
  5. Frontiers in oncology · 2023
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Dental Pulp-Derived Mesenchymal Stem Cells for Modeling Genetic Disorders.International journal of molecular sciences · 2021
    Review
  14. Article
  15. MELAS or Leigh syndrome, that's the question.Pediatric endocrinology, diabetes, and metabolism · 2021
    Article
  16. Article
  17. Article
  18. NovelGenes · 2020
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Eliana BonfanteDepartment of Diagnostic and Interventional Imaging, The University of Texas Medical School at Houston, 6431 Fannin St., MSB 2130b, Houston, TX, 77030, USA. eliana.e.bonfante.mejia@uth.tmc.edu.
Mary Kay KoenigDepartment of Pediatrics, Division of Child and Adolescent Neurology, Mitochondrial Center of Excellence Leigh Clinic, The University of Texas Medical School at Houston, Houston, TX, USA.
Rahmat B AdejumoDepartment of Pediatrics, Division of Child and Adolescent Neurology, The University of Texas Medical School at Houston, Houston, TX, USA.
Vinu PerinjelilDepartment of Pediatrics, Division of Child and Adolescent Neurology, The University of Texas Medical School at Houston, Houston, TX, USA.
Roy F RiascosDepartment of Diagnostic and Interventional Imaging, The University of Texas Medical School at Houston, Houston, TX, USA.
The University of Texas Health Science Center at Houston · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leigh syndrome by definition is (1) a neurodegenerative disease with variable symptoms, (2) caused by mitochondrial dysfunction from a hereditary genetic defect and (3) accompanied by bilateral central nervous system lesions. A genetic etiology is confirmed in approximately 50% of patients, with more than 60 identified mutations in the nuclear and mitochondrial genomes. Here we review the clinical features and imaging studies of Leigh syndrome and describe the neuroimaging findings in a cohort of 17 children with genetically confirmed Leigh syndrome. MR findings include lesions in the brainstem in 9 children (53%), basal ganglia in 13 (76%), thalami in 4 (24%) and dentate nuclei in 2 (12%), and global atrophy in 2 (12%). The brainstem lesions were most frequent in the midbrain and medulla oblongata. With follow-up an increased number of lesions from baseline was observed in 7 of 13 children, evolution of the initial lesion was seen in 6, and complete regression of the lesions was seen in 3. No cerebral white matter lesions were found in any of the 17 children. In concordance with the literature, we found that Leigh syndrome follows a similar pattern of bilateral, symmetrical basal ganglia or brainstem changes. Lesions in Leigh syndrome evolve over time and a lack of visible lesions does not exclude the diagnosis. Reversibility of lesions is seen in some patients, making the continued search for treatment and prevention a priority for clinicians and researchers.

Indexed as

BrainChild, PreschoolDiagnosis, DifferentialEvidence-Based MedicineHumansImage EnhancementInfantInfant, NewbornLeigh DiseaseMagnetic Resonance ImagingNeuroimagingBasal gangliaBrainstemChildrenLeigh syndromeMagnetic resonance imagingMitochondrial diseaseNecrotizing demyelination

Identifiers

PMID26739140
OpenAlexW2227296816

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.